Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Fresenius Medical Care AG (FMS) over the last 16 years, with Q3 2025 value amounting to $26.4 million.

  • Fresenius Medical Care AG's Deferred Taxes rose 18382.86% to $26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 11117.04%. This contributed to the annual value of -$77.7 million for FY2024, which is 4091.16% up from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Deferred Taxes is $26.4 million, which was up 18382.86% from -$25.6 million recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Deferred Taxes peaked at $91.6 million during Q4 2021, and registered a low of -$57.5 million during Q2 2022.
  • In the last 5 years, Fresenius Medical Care AG's Deferred Taxes had a median value of -$25.6 million in 2025 and averaged -$11.2 million.
  • In the last 5 years, Fresenius Medical Care AG's Deferred Taxes plummeted by 119309.97% in 2023 and then surged by 24149.98% in 2024.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Deferred Taxes stood at $91.6 million in 2021, then crashed by 79.28% to $19.0 million in 2022, then plummeted by 284.93% to -$35.1 million in 2023, then surged by 241.5% to $49.7 million in 2024, then tumbled by 46.93% to $26.4 million in 2025.
  • Its last three reported values are $26.4 million in Q3 2025, -$25.6 million for Q2 2025, and -$32.1 million during Q1 2025.